|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao H, Jiang M, Zhu M, Sheng F, Ruan J and
Ruan C: Overexpression of Annexin II affects the proliferation,
apoptosis, invasion and production of proangiogenic factors in
multiple myeloma. Int J Hematol. 90:177–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma MC and Sharma M: The role of
annexin II in angiogenesis and tumor progression: A potential
therapeutic target. Curr Pharm Des. 13:3568–3575. 2007. View Article : Google Scholar
|
|
4
|
Lokman NA, Ween MP, Oehler MK and
Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer
progression. Cancer Microenviron. 4:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerke V and Moss SE: Annexins: From
structure to function. Physiol Rev. 82:331–371. 2002.PubMed/NCBI
|
|
6
|
Rescher U and Gerke V: Annexins - unique
membrane binding proteins with diverse functions. J Cell Sci.
117:2631–2639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hajjar KA, Guevara CA, Lev E, Dowling K
and Chacko J: Interaction of the fibrinolytic receptor, annexin II,
with the endothelial cell surface. Essential role of endonexin
repeat 2. J Biol Chem. 271:21652–21659. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mai J, Finley RL Jr, Waisman DM and Sloane
BF: Human procathepsin B interacts with the annexin II tetramer on
the surface of tumor cells. J Biol Chem. 275:12806–12812. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Madureira PA, Surette AP, Phipps KD,
Taboski MA, Miller VA and Waisman DM: The role of the annexin A2
heterotetramer in vascular fibrinolysis. Blood. 118:4789–4797.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hajjar KA, Jacovina AT and Chacko J: An
endothelial cell receptor for plasminogen/tissue plasminogen
activator. I. Identity with annexin II. J Biol Chem.
269:21191–21197. 1994.PubMed/NCBI
|
|
11
|
Courtneidge S, Ralston R, Alitalo K and
Bishop JM: Subcellular location of an abundant substrate (p36) for
tyrosine-specific protein kinases. Mol Cell Biol. 3:340–350.
1983.PubMed/NCBI
|
|
12
|
Eberhard DA, Karns LR, VandenBerg SR and
Creutz CE: Control of the nuclear-cytoplasmic partitioning of
annexin II by a nuclear export signal and by p11 binding. J Cell
Sci. 114:3155–3166. 2001.PubMed/NCBI
|
|
13
|
Burger A, Berendes R, Liemann S, et al:
The crystal structure and ion channel activity of human annexin II,
a peripheral membrane protein. J Mol Biol. 257:839–847. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Camors E, Monceau V and Charlemagne D:
Annexins and Ca2+ handling in the heart. Cardiovasc Res.
65:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jost M, Thiel C, Weber K and Gerke V:
Mapping of three unique Ca2+-binding sites in human
annexin II. Eur J Biochem. 207:923–930. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jost M, Weber K and Gerke V: Annexin II
contains two types of Ca2+-binding sites. Biochem J.
298:553–559. 1994.
|
|
17
|
Filipenko NR, Kang HM and Waisman DM:
Characterization of the Ca2+-binding sites of annexin II
tetramer. J Biol Chem. 275:38877–38884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Filipenko NR and Waisman DM: The C
terminus of annexin II mediates binding to F-actin. J Biol Chem.
276:5310–5315. 2001. View Article : Google Scholar
|
|
19
|
Hayes MJ, Shao D, Bailly M and Moss SE:
Regulation of actin dynamics by annexin 2. EMBO J. 25:1816–1826.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jones PG, Moore GJ and Waisman DM: A
nonapeptide to the putative F-actin binding site of annexin-II
tetramer inhibits its calcium-dependent activation of actin
filament bundling. J Biol Chem. 267:13993–13997. 1992.PubMed/NCBI
|
|
21
|
Rescher U, Ruhe D, Ludwig C, Zobiack N and
Gerke V: Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate
binding protein recruited to actin assembly sites at cellular
membranes. J Cell Sci. 117:3473–3480. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su M, Shi JJ, Yang YP, Li J, Zhang YL,
Chen J, Hu LF and Liu CF: HDAC6 regulates aggresome-autophagy
degradation pathway of α-synuclein in response to
MPP+-induced stress. J Neurochem. 117:112–120. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aukrust I, Hollås H, Strand E, Evensen L,
Travé G, Flatmark T and Vedeler A: The mRNA-binding site of annexin
A2 resides in helices C-D of its domain IV. J Mol Biol.
368:1367–1378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kassam G, Manro A, Braat CE, Louie P,
Fitzpatrick SL and Waisman DM: Characterization of the heparin
binding properties of annexin II tetramer. J Biol Chem.
272:15093–15100. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vedeler A and Hollås H: Annexin II is
associated with mRNAs which may constitute a distinct
subpopulation. Biochem J. 348:565–572. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gould KL, Woodgett JR, Isacke CM and
Hunter T: The protein-tyrosine kinase substrate p36 is also a
substrate for protein kinase C in vitro and in vivo. Mol Cell Biol.
6:2738–2744. 1986.PubMed/NCBI
|
|
27
|
Jost M and Gerke V: Mapping of a
regulatory important site for protein kinase C phosphorylation in
the N-terminal domain of annexin II. Biochim Biophys Acta.
1313:283–289. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Glenney JR Jr and Tack BF: Amino-terminal
sequence of p36 and associated p10: Identification of the site of
tyrosine phosphorylation and homology with S-100. Proc Natl Acad
Sci USA. 82:7884–7888. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo W, Yan G, Li L, et al: Epstein-Barr
virus latent membrane protein 1 mediates serine 25 phosphorylation
and nuclear entry of annexin A2 via PI-PLC-PKCalpha/PKCbeta
pathway. Mol Carcinog. 47:934–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Graauw M, Tijdens I, Smeets MB,
Hensbergen PJ, Deelder AM and van de Water B: Annexin A2
phosphorylation mediates cell scattering and branching
morphogenesis via cofilin activation. Mol Cell Biol. 28:1029–1040.
2008. View Article : Google Scholar :
|
|
31
|
Morel E and Gruenberg J: Annexin A2
binding to endosomes and functions in endosomal transport are
regulated by tyrosine 23 phosphorylation. J Biol Chem.
284:1604–1611. 2009. View Article : Google Scholar
|
|
32
|
Hubaishy I, Jones PG, Bjorge J, Bellagamba
C, Fitzpatrick S, Fujita DJ and Waisman DM: Modulation of annexin
II tetramer by tyrosine phosphorylation. Biochemistry.
34:14527–14534. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Regnouf F, Sagot I, Delouche B, Devilliers
G, Cartaud J, Henry JP and Pradel LA: ‘In vitro’ phosphorylation of
annexin 2 heterotetramer by protein kinase C. Comparative
properties of the unphosphorylated and phosphorylated annexin 2 on
the aggregation and fusion of chromaffin granule membranes. J Biol
Chem. 270:27143–27150. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Johnstone SA, Hubaishy I and Waisman DM:
Phosphorylation of annexin II tetramer by protein kinase C inhibits
aggregation of lipid vesicles by the protein. J Biol Chem.
267:25976–25981. 1992.PubMed/NCBI
|
|
35
|
Deora AB, Kreitzer G, Jacovina AT and
Hajjar KA: An annexin 2 phosphorylation switch mediates
p11-dependent translocation of annexin 2 to the cell surface. J
Biol Chem. 279:43411–43418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng L, Foley K, Huang L, et al: Tyrosine
23 phosphorylation-dependent cell-surface localization of annexin
A2 is required for invasion and metastases of pancreatic cancer.
PLoS One. 6:e193902011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan G, Luo W, Lu Z, Luo X, Li L, Liu S,
Liu Y, Tang M, Dong Z and Cao Y: Epstein-Barr virus latent membrane
protein 1 mediates phosphorylation and nuclear translocation of
annexin A2 by activating PKC pathway. Cell Signal. 19:341–348.
2007. View Article : Google Scholar
|
|
38
|
Liu J, Rothermund CA, Ayala-Sanmartin J
and Vishwanatha JK: Nuclear annexin II negatively regulates growth
of LNCaP cells and substitution of ser 11 and 25 to glu prevents
nucleocytoplasmic shuttling of annexin II. BMC Biochem. 4:102003.
View Article : Google Scholar
|
|
39
|
Madureira PA, Hill R, Miller VA,
Giacomantonio C, Lee PW and Waisman DM: Annexin A2 is a novel
cellular redox regulatory protein involved in tumorigenesis.
Oncotarget. 2:1075–1093. 2011.PubMed/NCBI
|
|
40
|
Johnsson N, Marriott G and Weber K: p36,
the major cytoplasmic substrate of src tyrosine protein kinase,
binds to its p11 regulatory subunit via a short amino-terminal
amphiphatic helix. EMBO J. 7:2435–2442. 1988.PubMed/NCBI
|
|
41
|
Réty S, Sopkova J, Renouard M, Osterloh D,
Gerke V, Tabaries S, Russo-Marie F and Lewit-Bentley A: The crystal
structure of a complex of p11 with the annexin II N-terminal
peptide. Nat Struct Biol. 6:89–95. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Waisman DM: Annexin II tetramer: Structure
and function. Mol Cell Biochem. 149–150:301–322. 1995. View Article : Google Scholar
|
|
43
|
Kassam G, Choi KS, Ghuman J, Kang HM,
Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A and
Waisman DM: The role of annexin II tetramer in the activation of
plasminogen. J Biol Chem. 273:4790–4799. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cesarman GM, Guevara CA and Hajjar KA: An
endothelial cell receptor for plasminogen/tissue plasminogen
activator (t-PA). II. Annexin II-mediated enhancement of
t-PA-dependent plasminogen activation. J Biol Chem.
269:21198–21203. 1994.PubMed/NCBI
|
|
45
|
Hajjar KA and Krishnan S: Annexin II: A
mediator of the plasmin/plasminogen activator system. Trends
Cardiovasc Med. 9:128–138. 1999. View Article : Google Scholar
|
|
46
|
Jacovina AT, Deora AB, Ling Q, Broekman
MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD and Hajjar KA:
Homocysteine inhibits neoangiogenesis in mice through blockade of
annexin A2-dependent fibrinolysis. J Clin Invest. 119:3384–3394.
2009.PubMed/NCBI
|
|
47
|
Valapala M, Thamake SI and Vishwanatha JK:
A competitive hexapeptide inhibitor of annexin A2 prevents
hypoxia-induced angiogenic events. J Cell Sci. 124:1453–1464. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sharma M, Ownbey RT and Sharma MC: Breast
cancer cell surface annexin II induces cell migration and
neoangiogenesis via tPA dependent plasmin generation. Exp Mol
Pathol. 88:278–286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gerke V, Creutz CE and Moss SE: Annexins:
Linking Ca2+ signalling to membrane dynamics. Nat Rev
Mol Cell Biol. 6:449–461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ali SM, Geisow MJ and Burgoyne RD: A role
for calpactin in calcium-dependent exocytosis in adrenal chromaffin
cells. Nature. 340:313–315. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sarafian T, Pradel LA, Henry JP, Aunis D
and Bader MF: The participation of annexin II (calpactin I) in
calcium-evoked exocytosis requires protein kinase C. J Cell Biol.
114:1135–1147. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Morel E, Parton RG and Gruenberg J:
Annexin A2-dependent polymerization of actin mediates endosome
biogenesis. Dev Cell. 16:445–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yamada A, Irie K, Hirota T, Ooshio T,
Fukuhara A and Takai Y: Involvement of the annexin II-S100A10
complex in the formation of E-cadherin-based adherens junctions in
Madin-Darby canine kidney cells. J Biol Chem. 280:6016–6027. 2005.
View Article : Google Scholar
|
|
54
|
Mai J, Waisman DM and Sloane BF: Cell
surface complex of cathepsin B/annexin II tetramer in malignant
progression. Biochim Biophys Acta. 1477:215–230. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Grieve AG, Moss SE and Hayes MJ: Annexin
A2 at the interface of actin and membrane dynamics: A focus on its
roles in endocytosis and cell polarization. Int J Cell Biol.
2012:8524302012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jost M, Zeuschner D, Seemann J, Weber K
and Gerke V: Identification and characterization of a novel type of
annexin-membrane interaction: Ca2+ is not required for
the association of annexin II with early endosomes. J Cell Sci.
110:221–228. 1997.
|
|
57
|
König J and Gerke V: Modes of
annexin-membrane interactions analyzed by employing chimeric
annexin proteins. Biochim Biophys Acta. 1498:174–180. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu J and Vishwanatha JK: Regulation of
nucleo-cytoplasmic shuttling of human annexin A2: A proposed
mechanism. Mol Cell Biochem. 303:211–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jindal HK and Vishwanatha JK: Purification
and characterization of primer recognition proteins from HeLa
cells. Biochemistry. 29:4767–4773. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kumble KD and Vishwanatha JK:
Immunoelectron microscopic analysis of the intracellular
distribution of primer recognition proteins, annexin 2 and
phosphoglycerate kinase, in normal and transformed cells. J Cell
Sci. 99:751–758. 1991.PubMed/NCBI
|
|
61
|
Vishwanatha JK, Jindal HK and Davis RG:
The role of primer recognition proteins in DNA replication:
Association with nuclear matrix in HeLa cells. J Cell Sci.
101:25–34. 1992.PubMed/NCBI
|
|
62
|
Boyko V, Mudrak O, Svetlova M, Negishi Y,
Ariga H and Tomilin N: A major cellular substrate for protein
kinases, annexin II, is a DNA-binding protein. FEBS Lett.
345:139–142. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Krutilina RI, Babich VS, Kropotov AV,
Mudrak OS, Chesnokov IN, Turoverova LV, Konstantinova IM and
Tomilin NV: The DNA-binding activity of the membrane protein
annexin II and its interaction with antibodies to the chromatin
nuclear ribonucleoprotein (alpha-RNP). Tsitologiia. 38:1106–1114.
1996.In Russian.
|
|
64
|
Vishwanatha JK and Kumble S: Involvement
of annexin II in DNA replication: Evidence from cell-free extracts
of Xenopus eggs. J Cell Sci. 105:533–540. 1993.PubMed/NCBI
|
|
65
|
Kumble KD, Iversen PL and Vishwanatha JK:
The role of primer recognition proteins in DNA replication:
Inhibition of cellular proliferation by antisense
oligodeoxyribonucleotides. J Cell Sci. 101:35–41. 1992.PubMed/NCBI
|
|
66
|
Chiang Y, Rizzino A, Sibenaller ZA, Wold
MS and Vishwanatha JK: Specific down-regulation of annexin II
expression in human cells interferes with cell proliferation. Mol
Cell Biochem. 199:139–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Madureira PA, Hill R, Lee PW and Waisman
DM: Genotoxic agents promote the nuclear accumulation of annexin
A2: Role of annexin A2 in mitigating DNA damage. PLoS One.
7:e505912012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang CY, Chen CL, Tseng YL, Fang YT, Lin
YS, Su WC, Chen CC, Chang KC, Wang YC and Lin CF: Annexin A2
silencing induces G2 arrest of non-small cell lung cancer cells
through p53-dependent and -independent mechanisms. J Biol Chem.
287:32512–32524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Das S, Shetty P, Valapala M, Dasgupta S,
Gryczynski Z and Vishwanatha JK: Signal transducer and activator of
transcription 6 (STAT6) is a novel interactor of annexin A2 in
prostate cancer cells. Biochemistry. 49:2216–2226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Frohlich M, Motté P, Galvin K, Takahashi
H, Wands J and Ozturk M: Enhanced expression of the protein kinase
substrate p36 in human hepatocellular carcinoma. Mol Cell Biol.
10:3216–3223. 1990.PubMed/NCBI
|
|
71
|
Yang T, Peng H, Wang J, Yang J, Nice EC,
Xie K and Huang C: Prognostic and diagnostic significance of
annexin A2 in colorectal cancer. Colorectal Dis. 15:e373–e381.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Duncan R, Carpenter B, Main LC, Telfer C
and Murray GI: Characterisation and protein expression profiling of
annexins in colorectal cancer. Br J Cancer. 98:426–433. 2008.
View Article : Google Scholar
|
|
73
|
Deng S, Wang J, Hou L, Li J, Chen G, Jing
B, Zhang X and Yang Z: Annexin A1, A2, A4 and A5 play important
roles in breast cancer, pancreatic cancer and laryngeal carcinoma,
alone and/or synergistically. Oncol Lett. 5:107–112. 2013.
|
|
74
|
Shetty PK, Thamake SI, Biswas S, Johansson
SL and Vishwanatha JK: Reciprocal regulation of annexin A2 and EGFR
with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
PLoS One. 7:e442992012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sharma MR, Koltowski L, Ownbey RT,
Tuszynski GP and Sharma MC: Angiogenesis-associated protein annexin
II in breast cancer: Selective expression in invasive breast cancer
and contribution to tumor invasion and progression. Exp Mol Pathol.
81:146–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Chuthapisith S, Bean BE, Cowley G, et al:
Annexins in human breast cancer: Possible predictors of
pathological response to neoadjuvant chemotherapy. Eur J Cancer.
45:1274–1281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yao H, Zhang Z, Xiao Z, et al:
Identification of metastasis associated proteins in human lung
squamous carcinoma using two-dimensional difference gel
electrophoresis and laser capture microdissection. Lung Cancer.
65:41–48. 2009. View Article : Google Scholar
|
|
78
|
Zhang HJ, Yao DF, Yao M, Huang H, Wu W,
Yan MJ, Yan XD and Chen J: Expression characteristics and
diagnostic value of annexin A2 in hepatocellular carcinoma. World J
Gastroenterol. 18:5897–5904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang Q, Ye Z, Yang Q, He X, Wang H and
Zhao Z: Upregulated expression of annexin II is a prognostic marker
for patients with gastric cancer. World J Surg Oncol. 10:1032012.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Takano S, Togawa A, Yoshitomi H, et al:
Annexin II overexpression predicts rapid recurrence after surgery
in pancreatic cancer patients undergoing gemcitabine-adjuvant
chemotherapy. Ann Surg Oncol. 15:3157–3168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF
and Cheng CW: Annexin A2 in renal cell carcinoma: Expression,
function, and prognostic significance. Urol Oncol.
33:22.e11–22.e21. 2014. View Article : Google Scholar
|
|
82
|
Ma RL, Shen LY and Chen KN: Coexpression
of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal
squamous cell carcinoma. Oncol Rep. 31:2157–2164. 2014.PubMed/NCBI
|
|
83
|
Ohno Y, Izumi M, Kawamura T, Nishimura T,
Mukai K and Tachibana M: Annexin II represents metastatic potential
in clear-cell renal cell carcinoma. Br J Cancer. 101:287–294. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Emoto K, Sawada H, Yamada Y, et al:
Annexin II overexpression is correlated with poor prognosis in
human gastric carcinoma. Anticancer Res. 21:1339–1345.
2001.PubMed/NCBI
|
|
85
|
Liu Z, Ling Q, Wang J, Xie H, Xu X and
Zheng S: Annexin A2 is not a good biomarker for hepatocellular
carcinoma in cirrhosis. Oncol Lett. 6:125–129. 2013.PubMed/NCBI
|
|
86
|
Ji NY, Park MY, Kang YH, et al: Evaluation
of annexin II as a potential serum marker for hepatocellular
carcinoma using a developed sandwich ELISA method. Int J Mol Med.
24:765–771. 2009.PubMed/NCBI
|
|
87
|
Jeon YR, Kim SY, Lee EJ, Kim YN, Noh DY,
Park SY and Moon A: Identification of annexin II as a novel
secretory biomarker for breast cancer. Proteomics. 13:3145–3156.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC
and Liu YF: Prognostic significance of annexin II expression in
non-small cell lung cancer. Clin Transl Oncol. 15:938–946. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jia JW, Li KL, Wu JX and Guo SL: Clinical
significance of annexin II expression in human non-small cell lung
cancer. Tumour Biol. 34:1767–1771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Pei H, Zhu H, Zeng S, et al: Proteome
analysis and tissue microarray for profiling protein markers
associated with lymph node metastasis in colorectal cancer. J
Proteome Res. 6:2495–2501. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Emoto K, Yamada Y, Sawada H, Fujimoto H,
Ueno M, Takayama T, Kamada K, Naito A, Hirao S and Nakajima Y:
Annexin II overexpression correlates with stromal tenascin-C
overexpression: A prognostic marker in colorectal carcinoma.
Cancer. 92:1419–1426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Kagawa S, Takano S, Yoshitomi H, et al:
Akt/mTOR signaling pathway is crucial for gemcitabine resistance
induced by annexin II in pancreatic cancer cells. J Surg Res.
178:758–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Liu Z, Feng JG, Tuersun A, et al:
Proteomic identification of differentially-expressed proteins in
esophageal cancer in three ethnic groups in Xinjiang. Mol Biol Rep.
38:3261–3269. 2011. View Article : Google Scholar
|
|
94
|
Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou
C, Wu M and Liu Z: The deregulation of arachidonic acid
metabolism-related genes in human esophageal squamous cell
carcinoma. Int J Cancer. 106:327–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Pena-Alonso E, Rodrigo JP, Parra IC,
Pedrero JM, Meana MV, Nieto CS, Fresno MF, Morgan RO and Fernandez
MP: Annexin A2 localizes to the basal epithelial layer and is
down-regulated in dysplasia and head and neck squamous cell
carcinoma. Cancer Lett. 263:89–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Tressler RJ, Updyke TV, Yeatman T and
Nicolson GL: Extracellular annexin II is associated with divalent
cation-dependent tumor cell-endothelial cell adhesion of metastatic
RAW117 large-cell lymphoma cells. J Cell Biochem. 53:265–276. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lokman NA, Elder AS, Ween MP, Pyragius CE,
Hoffmann P, Oehler MK and Ricciardelli C: Annexin A2 is regulated
by ovarian cancer-peritoneal cell interactions and promotes
metastasis. Oncotarget. 4:1199–1211. 2013.PubMed/NCBI
|
|
98
|
Shiozawa Y, Havens AM, Jung Y, et al:
Annexin II/annexin II receptor axis regulates adhesion, migration,
homing, and growth of prostate cancer. J Cell Biochem. 105:370–380.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Myrvang HK, Guo X, Li C and Dekker LV:
Protein interactions between surface annexin A2 and S100A10 mediate
adhesion of breast cancer cells to microvascular endothelial cells.
FEBS Lett. 587:3210–3215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kumble KD, Hirota M, Pour PM and
Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma
cells of Syrian hamsters and their intrapancreatic allografts.
Cancer Res. 52:163–167. 1992.PubMed/NCBI
|
|
101
|
Claudio JO, Masih-Khan E, Tang H, et al: A
molecular compendium of genes expressed in multiple myeloma. Blood.
100:2175–2186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang YX, Lv H, Li ZX, Li C and Wu XY:
Effect of shRNA mediated down-regulation of annexin A2 on
biological behavior of human lung adencarcinoma cells A549. Pathol
Oncol Res. 18:183–190. 2012. View Article : Google Scholar
|
|
103
|
Zhang HJ, Yao DF, Yao M, Huang H, Wang L,
Yan MJ, Yan XD, Gu X, Wu W and Lu SL: Annexin A2 silencing inhibits
invasion, migration, and tumorigenic potential of hepatoma cells.
World J Gastroenterol. 19:3792–3801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang J, Guo B, Zhang Y, Cao J and Chen T:
Silencing of the annexin II gene down-regulates the levels of
S100A10, c-Myc, and plasmin and inhibits breast cancer cell
proliferation and invasion. Saudi Med J. 31:374–381.
2010.PubMed/NCBI
|
|
105
|
Filipenko NR, MacLeod TJ, Yoon CS and
Waisman DM: Annexin A2 is a novel RNA-binding protein. J Biol Chem.
279:8723–8731. 2004. View Article : Google Scholar
|
|
106
|
Mickleburgh I, Burtle B, Hollås H,
Campbell G, Chrzanowska-Lightowlers Z, Vedeler A and Hesketh J:
Annexin A2 binds to the localization signal in the 3′ untranslated
region of c-myc mRNA. FEBS J. 272:413–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Hollås H, Aukrust I, Grimmer S, Strand E,
Flatmark T and Vedeler A: Annexin A2 recognises a specific region
in the 3′-UTR of its cognate messenger RNA. Biochim Biophys Acta.
1763:1325–1334. 2006. View Article : Google Scholar
|
|
108
|
Pelengaris S and Khan M: The c-MYC
oncoprotein as a treatment target in cancer and other disorders of
cell growth. Expert Opin Ther Targets. 7:623–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen
F, Zhao YZ and Fu SB: Involvement of annexin A2 in p53 induced
apoptosis in lung cancer. Mol Cell Biochem. 309:117–123. 2008.
View Article : Google Scholar
|
|
110
|
Rengifo-Cam W, Umar S, Sarkar S and Singh
P: Antiapoptotic effects of progastrin on pancreatic cancer cells
are mediated by sustained activation of nuclear factor-κB. Cancer
Res. 67:7266–7274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sarkar S, Swiercz R, Kantara C, Hajjar KA
and Singh P: Annexin A2 mediates up-regulation of NF-κB, β-catenin,
and stem cell in response to progastrin in mice and HEK-293 cells.
Gastroenterology. 140:583.e4–595.e4. 2011. View Article : Google Scholar
|
|
112
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lima e Silva R, Shen J, Gong YY, Seidel
CP, Hackett SF, Kesavan K, Jacoby DB and Campochiaro PA: Agents
that bind annexin A2 suppress ocular neovascularization. J Cell
Physiol. 225:855–864. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Sharma M, Blackman MR and Sharma MC:
Antibody-directed neutralization of annexin II (ANX II) inhibits
neoangiogenesis and human breast tumor growth in a xenograft model.
Exp Mol Pathol. 92:175–184. 2012. View Article : Google Scholar
|
|
121
|
Carmeliet P: Mechanisms of angiogenesis
and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhao S, Huang L, Wu J, Zhang Y, Pan D and
Liu X: Vascular endothelial growth factor upregulates expression of
annexin A2 in vitro and in a mouse model of ischemic retinopathy.
Mol Vis. 15:1231–1242. 2009.PubMed/NCBI
|
|
123
|
Raddum AM, Evensen L, Hollås H, Grindheim
AK, Lorens JB and Vedeler A: Domains I and IV of annexin A2 affect
the formation and integrity of in vitro capillary-like networks.
PLoS One. 8:e602812013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Dejana E, Orsenigo F and Lampugnani MG:
The role of adherens junctions and VE-cadherin in the control of
vascular permeability. J Cell Sci. 121:2115–2122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Su SC, Maxwell SA and Bayless KJ: Annexin
2 regulates endothelial morphogenesis by controlling AKT activation
and junctional integrity. J Biol Chem. 285:40624–40634. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC,
Zhou X and Ding YT: Endothelial precursor cells promote
angiogenesis in hepatocellular carcinoma. World J Gastroenterol.
18:4925–4933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Yu DC, Chen J, Sun XT, Zhuang LY, Jiang CP
and Ding YT: Mechanism of endothelial progenitor cell recruitment
into neo-vessels in adjacent non-tumor tissues in hepatocellular
carcinoma. BMC Cancer. 10:4352010. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Finney MR, Greco NJ, Haynesworth SE, et
al: Direct comparison of umbilical cord blood versus bone
marrow-derived endothelial precursor cells in mediating
neovascularization in response to vascular ischemia. Biol Blood
Marrow Transplant. 12:585–593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Pollard TD and Borisy GG: Cellular
motility driven by assembly and disassembly of actin filaments.
Cell. 112:453–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Revenu C, Athman R, Robine S and Louvard
D: The co-workers of actin filaments: From cell structures to
signals. Nat Rev Mol Cell Biol. 5:635–646. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wei J, Liu Y, Chang M, Sun CL, Li DW, Liu
ZQ and Hu LS: Proteomic analysis of oxidative modification in
endothelial colony-forming cells treated by hydrogen peroxide. Int
J Mol Med. 29:1099–1105. 2012.PubMed/NCBI
|
|
132
|
Zhang X, Cui X, Cheng L, Guan X, Li H, Li
X and Cheng M: Actin stabilization by jasplakinolide affects the
function of bone marrow-derived late endothelial progenitor cells.
PLoS One. 7:e508992012. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhang F, Zhang L, Zhang B, Wei X, Yang Y,
Qi RZ, Ying G, Zhang N and Niu R: Anxa2 plays a critical role in
enhanced invasiveness of the multidrug resistant human breast
cancer cells. J Proteome Res. 8:5041–5047. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Wu W, Tang X, Hu W, Lotan R, Hong WK and
Mao L: Identification and validation of metastasis-associated
proteins in head and neck cancer cell lines by two-dimensional
electrophoresis and mass spectrometry. Clin Exp Metastasis.
19:319–326. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Maruo T, Ichikawa T, Kanzaki H, et al:
Proteomics-based analysis of invasion-related proteins in malignant
gliomas. Neuropathology. 33:264–275. 2013. View Article : Google Scholar
|
|
136
|
Tatenhorst L, Rescher U, Gerke V and
Paulus W: Knockdown of annexin 2 decreases migration of human
glioma cells in vitro. Neuropathol Appl Neurobiol. 32:271–277.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Mignatti P and Rifkin DB: Biology and
biochemistry of proteinases in tumor invasion. Physiol Rev.
73:161–195. 1993.PubMed/NCBI
|
|
138
|
McColl BK, Baldwin ME, Roufail S, Freeman
C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA and Achen MG:
Plasmin activates the lymphangiogenic growth factors VEGF-C and
VEGF-D. J Exp Med. 198:863–868. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Bajou K, Masson V, Gerard RD, et al: The
plasminogen activator inhibitor PAI-1 controls in vivo tumor
vascularization by interaction with proteases, not vitronectin.
Implications for antiangiogenic strategies. J Cell Biol.
152:777–784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Díaz VM, Planaguma J, Thomson TM, Reventós
J and Paciucci R: Tissue plasminogen activator is required for the
growth, invasion, and angiogenesis of pancreatic tumor cells.
Gastroenterology. 122:806–819. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Pepper MS: Extracellular proteolysis and
angiogenesis. Thromb Haemost. 86:346–355. 2001.PubMed/NCBI
|
|
142
|
Tarui T, Majumdar M, Miles LA, Ruf W and
Takada Y: Plasmin-induced migration of endothelial cells. A
potential target for the anti-angiogenic action of angiostatin. J
Biol Chem. 277:33564–33570. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Ranson M and Andronicos NM: Plasminogen
binding and cancer: Promises and pitfalls. Front Biosci.
8:s294–s304. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
144
|
Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang
H, Han J and Niu R: Up-regulation of Anxa2 gene promotes
proliferation and invasion of breast cancer MCF-7 cells. Cell
Prolif. 45:189–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhang W, Zhao P, Xu XL, Cai L, Song ZS,
Cao DY, Tao KS, Zhou WP, Chen ZN and Dou KF: Annexin A2 promotes
the migration and invasion of human hepatocellular carcinoma cells
in vitro by regulating the shedding of CD147-harboring
microvesicles from tumor cells. PLoS One. 8:e672682013. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li
Y, Jiang JL, Zhang SH and Chen ZN: Annexin II promotes invasion and
migration of human hepatocellular carcinoma cells in vitro via its
interaction with HAb18G/CD147. Cancer Sci. 101:387–395. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Nedjadi T, Kitteringham N, Campbell F,
Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos
JP and Costello E: S100A6 binds to annexin 2 in pancreatic cancer
cells and promotes pancreatic cancer cell motility. Br J Cancer.
101:1145–1154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
